Telangiectasia Clinical Trials in Portland, Oregon
2 recruitingPortland, Oregon
Showing 1–2 of 2 trials
Recruiting
Phase 4
Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants
Macular Telangiectasia Type 2 (MacTel)
Neurotech Pharmaceuticals285 enrolled26 locationsNCT06971939
Recruiting
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
Gastrointestinal BleedingTelangiectasiaArteriovenous Malformations+4 more
Cure HHT10,000 enrolled16 locationsNCT06259292